TEDAR: Temporal dynamic signal detection of adverse reactions
Computational approaches to detect the signals of adverse drug reactions are powerful tools to monitor the unattended effects that users experience and report, also preventing death and serious injury. They apply statistical indices to affirm the validity of adverse reactions reported by users. The...
Saved in:
| Published in: | Artificial intelligence in medicine Vol. 122; p. 102212 |
|---|---|
| Main Authors: | , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Netherlands
Elsevier B.V
01.12.2021
|
| Subjects: | |
| ISSN: | 0933-3657, 1873-2860, 1873-2860 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Computational approaches to detect the signals of adverse drug reactions are powerful tools to monitor the unattended effects that users experience and report, also preventing death and serious injury. They apply statistical indices to affirm the validity of adverse reactions reported by users. The methodologies that scan fixed duration intervals in the lifetime of drugs are among the most used. Here we present a method, called TEDAR, in which ranges of varying length are taken into account. TEDAR has the advantage to detect a greater number of true signals without significantly increasing the number of false positives, which are a major concern for this type of tools. Furthermore, early detection of signals is a key feature of methods to prevent the safety of the population. The results show that TEDAR detects adverse reactions many months earlier than methodologies based on a fixed interval length.
•Detection of signals in pharmacovigilance datasets is improved by temporal dynamics.•TEDAR detects a greater number of true signals without increasing false positives.•TEDAR detects adverse reactions months before the other methodologies. |
|---|---|
| AbstractList | Computational approaches to detect the signals of adverse drug reactions are powerful tools to monitor the unattended effects that users experience and report, also preventing death and serious injury. They apply statistical indices to affirm the validity of adverse reactions reported by users. The methodologies that scan fixed duration intervals in the lifetime of drugs are among the most used. Here we present a method, called TEDAR, in which ranges of varying length are taken into account. TEDAR has the advantage to detect a greater number of true signals without significantly increasing the number of false positives, which are a major concern for this type of tools. Furthermore, early detection of signals is a key feature of methods to prevent the safety of the population. The results show that TEDAR detects adverse reactions many months earlier than methodologies based on a fixed interval length.Computational approaches to detect the signals of adverse drug reactions are powerful tools to monitor the unattended effects that users experience and report, also preventing death and serious injury. They apply statistical indices to affirm the validity of adverse reactions reported by users. The methodologies that scan fixed duration intervals in the lifetime of drugs are among the most used. Here we present a method, called TEDAR, in which ranges of varying length are taken into account. TEDAR has the advantage to detect a greater number of true signals without significantly increasing the number of false positives, which are a major concern for this type of tools. Furthermore, early detection of signals is a key feature of methods to prevent the safety of the population. The results show that TEDAR detects adverse reactions many months earlier than methodologies based on a fixed interval length. Computational approaches to detect the signals of adverse drug reactions are powerful tools to monitor the unattended effects that users experience and report, also preventing death and serious injury. They apply statistical indices to affirm the validity of adverse reactions reported by users. The methodologies that scan fixed duration intervals in the lifetime of drugs are among the most used. Here we present a method, called TEDAR, in which ranges of varying length are taken into account. TEDAR has the advantage to detect a greater number of true signals without significantly increasing the number of false positives, which are a major concern for this type of tools. Furthermore, early detection of signals is a key feature of methods to prevent the safety of the population. The results show that TEDAR detects adverse reactions many months earlier than methodologies based on a fixed interval length. Computational approaches to detect the signals of adverse drug reactions are powerful tools to monitor the unattended effects that users experience and report, also preventing death and serious injury. They apply statistical indices to affirm the validity of adverse reactions reported by users. The methodologies that scan fixed duration intervals in the lifetime of drugs are among the most used. Here we present a method, called TEDAR, in which ranges of varying length are taken into account. TEDAR has the advantage to detect a greater number of true signals without significantly increasing the number of false positives, which are a major concern for this type of tools. Furthermore, early detection of signals is a key feature of methods to prevent the safety of the population. The results show that TEDAR detects adverse reactions many months earlier than methodologies based on a fixed interval length. •Detection of signals in pharmacovigilance datasets is improved by temporal dynamics.•TEDAR detects a greater number of true signals without increasing false positives.•TEDAR detects adverse reactions months before the other methodologies. |
| ArticleNumber | 102212 |
| Author | Bonnici, Vincenzo Giugno, Rosalba Sala, Pietro Aparo, Antonino |
| Author_xml | – sequence: 1 givenname: Antonino surname: Aparo fullname: Aparo, Antonino – sequence: 2 givenname: Pietro surname: Sala fullname: Sala, Pietro email: pietro.sala@univr.it – sequence: 3 givenname: Vincenzo surname: Bonnici fullname: Bonnici, Vincenzo – sequence: 4 givenname: Rosalba surname: Giugno fullname: Giugno, Rosalba email: rosalba.giugno@univr.it |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34823837$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkE1Lw0AQhhdRtFb_gUiOXlL3M7sRFcRvKAhSz8t0M5Gt-ai7qdB_b2r04qWnYYb3eWGeQ7LbtA0ScsLohFGWnS8mELoaiwmnnPUnzhnfISNmtEi5yeguGdFciFRkSh-QwxgXlFItWbZPDoQ0XBihR-Rqdn9383qRzLBetgGqpFg3UHuXRP_ebFbs0HW-bZK2TKD4whAxCQg_t3hE9kqoIh7_zjF5e7if3T6l05fH59ubaeokU10qNchcoeZgDOVljgyM5qWWDlVmcnQ6Q6mAKlTAGDdCAKfzjBUsV3xeghiTs6F3GdrPFcbO1j46rCposF1FyzMqeydKiT56-htdzXs7dhl8DWFt_17uAxdDwIU2xoCldb6DzTtdAF9ZRu3Gr13Ywa_d-LWD3x6W_-C__i3Y9YBhL-nLY7DReWwcFj70em3R-m0Fl_8KXOUb76D6wPV2_BuH8qgK |
| CitedBy_id | crossref_primary_10_1111_bcp_16012 |
| Cites_doi | 10.1002/9781119413431.ch10 10.3390/ijerph16122221 10.1002/pds.4672 10.1007/s40264-015-0345-1 10.1002/pds.4184 10.3390/life10080138 10.1002/pds.677 10.2165/11534410-000000000-00000 10.1080/00031305.1999.10474456 10.1186/s12911-017-0472-y 10.1002/sim.8447 10.1177/2042098619882819 10.1007/s40264-015-0289-5 10.1093/nar/gku1066 10.1177/0962280216643116 10.1002/pds.1742 10.1002/pds.1001 10.1007/s40264-016-0405-1 10.1007/s002280050466 |
| ContentType | Journal Article |
| Copyright | 2021 Copyright © 2021. Published by Elsevier B.V. |
| Copyright_xml | – notice: 2021 – notice: Copyright © 2021. Published by Elsevier B.V. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.artmed.2021.102212 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Computer Science |
| EISSN | 1873-2860 |
| ExternalDocumentID | 34823837 10_1016_j_artmed_2021_102212 S0933365721002050 |
| Genre | Journal Article |
| GroupedDBID | --- --K --M .1- .DC .FO .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 23N 4.4 457 4G. 53G 5GY 5VS 7-5 71M 77I 77K 8P~ 9JM 9JN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAWTL AAXKI AAXUO AAYFN AAYWO ABBOA ABBQC ABFNM ABIVO ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFS ACIEU ACIUM ACLOT ACNNM ACRLP ACRPL ACVFH ACZNC ADBBV ADCNI ADEZE ADJOM ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGQPQ AGUBO AGYEJ AHHHB AHZHX AIALX AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX AOUOD APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA GBOLZ HEA HMK HMO HVGLF HZ~ IHE J1W KOM LZ2 M29 M41 MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SDF SDG SDP SEL SES SEW SPC SPCBC SSH SSV SSZ T5K UHS WH7 WUQ Z5R ~G- ~HD AACTN AAIAV ABLVK ABYKQ AFCTW AFKWA AJBFU AJOXV AMFUW LCYCR RIG 9DU AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c415t-47a495e72a8802f9e1a872f74ce5689ec76e45a05e5a112833a20b61d1952bfa3 |
| ISICitedReferencesCount | 1 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000722509400002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0933-3657 1873-2860 |
| IngestDate | Sat Sep 27 20:47:31 EDT 2025 Thu Apr 03 06:56:34 EDT 2025 Sat Nov 29 07:07:29 EST 2025 Tue Nov 18 21:02:40 EST 2025 Fri Feb 23 02:41:57 EST 2024 Tue Oct 14 19:30:14 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | ESD Dynamic temporal intervals Graph-based algorithm DTI Adverse drug reactions Early signal detection Pharmacovigilance datasets Signal detection ADR |
| Language | English |
| License | Copyright © 2021. Published by Elsevier B.V. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c415t-47a495e72a8802f9e1a872f74ce5689ec76e45a05e5a112833a20b61d1952bfa3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 34823837 |
| PQID | 2604016553 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2604016553 pubmed_primary_34823837 crossref_citationtrail_10_1016_j_artmed_2021_102212 crossref_primary_10_1016_j_artmed_2021_102212 elsevier_sciencedirect_doi_10_1016_j_artmed_2021_102212 elsevier_clinicalkey_doi_10_1016_j_artmed_2021_102212 |
| PublicationCentury | 2000 |
| PublicationDate | December 2021 2021-12-00 20211201 |
| PublicationDateYYYYMMDD | 2021-12-01 |
| PublicationDate_xml | – month: 12 year: 2021 text: December 2021 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Artificial intelligence in medicine |
| PublicationTitleAlternate | Artif Intell Med |
| PublicationYear | 2021 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Bate, Lindquist, Edwards, Olsson, Orre, Lansner, De Freitas (bb0045) 1998; 54 MedDRA MSSO (bb0120) 2010 AIFA Official Website (bb0010) Ji, Shen, Tran (bb0035) 2014 Bate, Evans (bb0050) 2009; 18 Wisniewski, Bate, Bousquet, Brueckner, Candore, Juhlin, Macia-Martinez, Manlik, Quarcoo, Seabroke (bb0100) 2016; 39 Ahmed, Pariente, Tubert-Bitter (bb0070) 2018; 27 Dekking, Kraaikamp, Lopuhaä, Meester (bb0115) 2005 Fukazawa, Hinomura, Kaneko, Narukawa (bb0065) 2018; 27 ICH M5 Expert Working Group (bb0125) 2005 Zhou, Pool, Iskander, English-Bullard, Ball, Wise, Haber, Pless, Mootrey, Ellenberg (bb0020) 2003; 52 Poudel, Acharya, Ghimire, Dhital, Bharati (bb0005) 2017; 26 Evans, Waller, Davis (bb0030) 2001; 10 Park, Jung, Heo, Jung (bb0090) 2020; 10 Lerch, Nowicki, Manlik, Wirsching (bb0080) 2015; 38 Sardella, Lungu (bb0075) 2019; 10 Dal Pan, Lindquist, Gelperin (bb0025) 2019 Ding, Markatou, Ball (bb0095) 2020; 39 Cai, Du, Huang, Ellenberg, Hennessy, Tao, Chen (bb0015) 2017; 17 Rothman, Lanes, Sacks (bb0040) 2004; 13 Cai, Xu, Pan, Pan, Ji, Li, Jin, Liu, Ji (bb0105) 2014; 43 Candore, Juhlin, Manlik, Thakrar, Quarcoo, Seabroke, Wisniewski, Slattery (bb0085) 2015; 38 U. S. Food, Drug Administration US FDA (bb0140) 1989 De Pretis, Osimani (bb0060) 2019; 16 Alvarez, Hidalgo, Maignen, Slattery (bb0130) 2010; 33 Kuhn, Letunic, Jensen, Bork (bb0135) 2015; 44 DuMouchel (bb0055) 1999; 53 EudraVigilance Expert Working Group (bb0110) 2006 Candore (10.1016/j.artmed.2021.102212_bb0085) 2015; 38 EudraVigilance Expert Working Group (10.1016/j.artmed.2021.102212_bb0110) MedDRA MSSO (10.1016/j.artmed.2021.102212_bb0120) U. S. Food (10.1016/j.artmed.2021.102212_bb0140) 1989 Rothman (10.1016/j.artmed.2021.102212_bb0040) 2004; 13 ICH M5 Expert Working Group (10.1016/j.artmed.2021.102212_bb0125) Zhou (10.1016/j.artmed.2021.102212_bb0020) 2003; 52 Cai (10.1016/j.artmed.2021.102212_bb0015) 2017; 17 Poudel (10.1016/j.artmed.2021.102212_bb0005) 2017; 26 Wisniewski (10.1016/j.artmed.2021.102212_bb0100) 2016; 39 Dekking (10.1016/j.artmed.2021.102212_bb0115) 2005 Sardella (10.1016/j.artmed.2021.102212_bb0075) 2019; 10 Lerch (10.1016/j.artmed.2021.102212_bb0080) 2015; 38 Bate (10.1016/j.artmed.2021.102212_bb0050) 2009; 18 Cai (10.1016/j.artmed.2021.102212_bb0105) 2014; 43 Ding (10.1016/j.artmed.2021.102212_bb0095) 2020; 39 AIFA Official Website (10.1016/j.artmed.2021.102212_bb0010) Ji (10.1016/j.artmed.2021.102212_bb0035) 2014 Fukazawa (10.1016/j.artmed.2021.102212_bb0065) 2018; 27 Ahmed (10.1016/j.artmed.2021.102212_bb0070) 2018; 27 Alvarez (10.1016/j.artmed.2021.102212_bb0130) 2010; 33 Park (10.1016/j.artmed.2021.102212_bb0090) 2020; 10 Bate (10.1016/j.artmed.2021.102212_bb0045) 1998; 54 De Pretis (10.1016/j.artmed.2021.102212_bb0060) 2019; 16 Dal Pan (10.1016/j.artmed.2021.102212_bb0025) 2019 DuMouchel (10.1016/j.artmed.2021.102212_bb0055) 1999; 53 Kuhn (10.1016/j.artmed.2021.102212_bb0135) 2015; 44 Evans (10.1016/j.artmed.2021.102212_bb0030) 2001; 10 |
| References_xml | – volume: 10 year: 2019 ident: bb0075 article-title: Evaluation of quantitative signal detection in EudraVigilance for orphan drugs: possible risk of false negatives publication-title: Ther Adv Drug Saf – volume: 38 start-page: 1219 year: 2015 end-page: 1231 ident: bb0080 article-title: Statistical signal detection as a routine pharmacovigilance practice: effects of periodicity and resignalling criteria on quality and workload publication-title: Drug Saf – volume: 10 start-page: 138 year: 2020 ident: bb0090 article-title: Comparison of data mining methods for the signal detection of adverse drug events with a hierarchical structure in postmarketing surveillance publication-title: Life – volume: 17 start-page: 76 year: 2017 ident: bb0015 article-title: A signal detection method for temporal variation of adverse effect with vaccine adverse event reporting system data publication-title: BMC Med Inform Decis Mak – volume: 13 start-page: 519 year: 2004 end-page: 523 ident: bb0040 article-title: The reporting odds ratio and its advantages over the proportional reporting ratio publication-title: Pharmacoepidemiol Drug Saf – volume: 39 start-page: 469 year: 2016 end-page: 490 ident: bb0100 article-title: Good signal detection practices: evidence from IMI PROTECT publication-title: Drug Saf – year: 1989 ident: bb0140 article-title: Guidance for the In Vitro Portion of Bioequivalence Requirements for Metaproterenol Sulfate and Albuterol Inhalation Aerosol – volume: 38 start-page: 577 year: 2015 end-page: 587 ident: bb0085 article-title: Comparison of statistical signal detection methods within and across spontaneous reporting databases publication-title: Drug Saf – volume: 54 start-page: 315 year: 1998 end-page: 321 ident: bb0045 article-title: A bayesian neural network method for adverse drug reaction signal generation publication-title: Eur J Clin Pharmacol – volume: 18 start-page: 427 year: 2009 end-page: 436 ident: bb0050 article-title: Quantitative signal detection using spontaneous ADR reporting publication-title: Pharmacoepidemiol Drug Saf – volume: 39 start-page: 845 year: 2020 end-page: 874 ident: bb0095 article-title: An evaluation of statistical approaches to postmarketing surveillance publication-title: Stat Med – year: 2010 ident: bb0120 article-title: About MedDRA – volume: 43 start-page: D907 year: 2014 end-page: D913 ident: bb0105 article-title: ADReCS: an ontology database for aiding standardization and hierarchical classification of adverse drug reaction terms publication-title: Nucleic Acids Res – year: 2005 ident: bb0115 article-title: A modern introduction to probability and statistics: understanding why and how – ident: bb0010 – start-page: 165 year: 2019 end-page: 201 ident: bb0025 article-title: Postmarketing spontaneous pharmacovigilance reporting systems publication-title: Pharmacoepidemiology – volume: 33 start-page: 475 year: 2010 end-page: 487 ident: bb0130 article-title: Validation of statistical signal detection procedures in EudraVigilance post-authorization data publication-title: Drug Saf – volume: 44 year: 2015 ident: bb0135 article-title: The SIDER database of drugs and side effects – volume: 53 start-page: 177 year: 1999 end-page: 190 ident: bb0055 article-title: Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system publication-title: Am Stat – volume: 26 start-page: 635 year: 2017 end-page: 641 ident: bb0005 article-title: Burden of hospitalizations related to adverse drug events in the USA: a retrospective analysis from large inpatient database publication-title: Pharmacoepidemiol Drug Saf – volume: 10 start-page: 483 year: 2001 end-page: 486 ident: bb0030 article-title: Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports publication-title: Pharmacoepidemiol Drug Saf – start-page: 407 year: 2014 end-page: 412 ident: bb0035 article-title: A multi-relational association mining algorithm for screening suspected adverse drug reactions publication-title: 2014 11th International Conference on Information Technology: New Generations, IEEE – year: 2006 ident: bb0110 article-title: Guideline on good pharmacovigilance practices (GVP), Module IX Addendum I – volume: 16 start-page: 2221 year: 2019 ident: bb0060 article-title: New insights in computational methods for pharmacovigilance: E-synthesis, a bayesian framework for causal assessment publication-title: Int J Environ Res Public Health – volume: 27 start-page: 785 year: 2018 end-page: 797 ident: bb0070 article-title: Class-imbalanced subsampling lasso algorithm for discovering adverse drug reactions publication-title: Stat Methods Med Res – volume: 52 start-page: 1 year: 2003 end-page: 24 ident: bb0020 article-title: Surveillance for safety after immunization: vaccine adverse event reporting system (VAERS)—United States, 1991–2001 publication-title: MMWR Surveill Summ – volume: 27 start-page: 1402 year: 2018 end-page: 1408 ident: bb0065 article-title: Significance of data mining in routine signal detection: analysis based on the safety signals identified by the FDA publication-title: Pharmacoepidemiol Drug Saf – year: 2005 ident: bb0125 article-title: Data elements and standard for drug dictionaries M5 – year: 2005 ident: 10.1016/j.artmed.2021.102212_bb0115 – start-page: 165 year: 2019 ident: 10.1016/j.artmed.2021.102212_bb0025 article-title: Postmarketing spontaneous pharmacovigilance reporting systems publication-title: Pharmacoepidemiology doi: 10.1002/9781119413431.ch10 – volume: 16 start-page: 2221 issue: 12 year: 2019 ident: 10.1016/j.artmed.2021.102212_bb0060 article-title: New insights in computational methods for pharmacovigilance: E-synthesis, a bayesian framework for causal assessment publication-title: Int J Environ Res Public Health doi: 10.3390/ijerph16122221 – ident: 10.1016/j.artmed.2021.102212_bb0125 – volume: 27 start-page: 1402 issue: 12 year: 2018 ident: 10.1016/j.artmed.2021.102212_bb0065 article-title: Significance of data mining in routine signal detection: analysis based on the safety signals identified by the FDA publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.4672 – volume: 38 start-page: 1219 issue: 12 year: 2015 ident: 10.1016/j.artmed.2021.102212_bb0080 article-title: Statistical signal detection as a routine pharmacovigilance practice: effects of periodicity and resignalling criteria on quality and workload publication-title: Drug Saf doi: 10.1007/s40264-015-0345-1 – volume: 26 start-page: 635 issue: 6 year: 2017 ident: 10.1016/j.artmed.2021.102212_bb0005 article-title: Burden of hospitalizations related to adverse drug events in the USA: a retrospective analysis from large inpatient database publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.4184 – volume: 10 start-page: 138 issue: 8 year: 2020 ident: 10.1016/j.artmed.2021.102212_bb0090 article-title: Comparison of data mining methods for the signal detection of adverse drug events with a hierarchical structure in postmarketing surveillance publication-title: Life doi: 10.3390/life10080138 – volume: 10 start-page: 483 issue: 6 year: 2001 ident: 10.1016/j.artmed.2021.102212_bb0030 article-title: Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.677 – volume: 44 issue: D1 year: 2015 ident: 10.1016/j.artmed.2021.102212_bb0135 article-title: The SIDER database of drugs and side effects – volume: 33 start-page: 475 issue: 6 year: 2010 ident: 10.1016/j.artmed.2021.102212_bb0130 article-title: Validation of statistical signal detection procedures in EudraVigilance post-authorization data publication-title: Drug Saf doi: 10.2165/11534410-000000000-00000 – volume: 53 start-page: 177 issue: 3 year: 1999 ident: 10.1016/j.artmed.2021.102212_bb0055 article-title: Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system publication-title: Am Stat doi: 10.1080/00031305.1999.10474456 – ident: 10.1016/j.artmed.2021.102212_bb0010 – volume: 17 start-page: 76 issue: 2 year: 2017 ident: 10.1016/j.artmed.2021.102212_bb0015 article-title: A signal detection method for temporal variation of adverse effect with vaccine adverse event reporting system data publication-title: BMC Med Inform Decis Mak doi: 10.1186/s12911-017-0472-y – volume: 39 start-page: 845 issue: 7 year: 2020 ident: 10.1016/j.artmed.2021.102212_bb0095 article-title: An evaluation of statistical approaches to postmarketing surveillance publication-title: Stat Med doi: 10.1002/sim.8447 – ident: 10.1016/j.artmed.2021.102212_bb0110 – volume: 52 start-page: 1 issue: 1 year: 2003 ident: 10.1016/j.artmed.2021.102212_bb0020 article-title: Surveillance for safety after immunization: vaccine adverse event reporting system (VAERS)—United States, 1991–2001 publication-title: MMWR Surveill Summ – volume: 10 year: 2019 ident: 10.1016/j.artmed.2021.102212_bb0075 article-title: Evaluation of quantitative signal detection in EudraVigilance for orphan drugs: possible risk of false negatives publication-title: Ther Adv Drug Saf doi: 10.1177/2042098619882819 – volume: 38 start-page: 577 issue: 6 year: 2015 ident: 10.1016/j.artmed.2021.102212_bb0085 article-title: Comparison of statistical signal detection methods within and across spontaneous reporting databases publication-title: Drug Saf doi: 10.1007/s40264-015-0289-5 – volume: 43 start-page: D907 issue: D1 year: 2014 ident: 10.1016/j.artmed.2021.102212_bb0105 article-title: ADReCS: an ontology database for aiding standardization and hierarchical classification of adverse drug reaction terms publication-title: Nucleic Acids Res doi: 10.1093/nar/gku1066 – ident: 10.1016/j.artmed.2021.102212_bb0120 – volume: 27 start-page: 785 issue: 3 year: 2018 ident: 10.1016/j.artmed.2021.102212_bb0070 article-title: Class-imbalanced subsampling lasso algorithm for discovering adverse drug reactions publication-title: Stat Methods Med Res doi: 10.1177/0962280216643116 – year: 1989 ident: 10.1016/j.artmed.2021.102212_bb0140 – volume: 18 start-page: 427 issue: 6 year: 2009 ident: 10.1016/j.artmed.2021.102212_bb0050 article-title: Quantitative signal detection using spontaneous ADR reporting publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.1742 – start-page: 407 year: 2014 ident: 10.1016/j.artmed.2021.102212_bb0035 article-title: A multi-relational association mining algorithm for screening suspected adverse drug reactions – volume: 13 start-page: 519 issue: 8 year: 2004 ident: 10.1016/j.artmed.2021.102212_bb0040 article-title: The reporting odds ratio and its advantages over the proportional reporting ratio publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.1001 – volume: 39 start-page: 469 issue: 6 year: 2016 ident: 10.1016/j.artmed.2021.102212_bb0100 article-title: Good signal detection practices: evidence from IMI PROTECT publication-title: Drug Saf doi: 10.1007/s40264-016-0405-1 – volume: 54 start-page: 315 issue: 4 year: 1998 ident: 10.1016/j.artmed.2021.102212_bb0045 article-title: A bayesian neural network method for adverse drug reaction signal generation publication-title: Eur J Clin Pharmacol doi: 10.1007/s002280050466 |
| SSID | ssj0007416 |
| Score | 2.3107204 |
| Snippet | Computational approaches to detect the signals of adverse drug reactions are powerful tools to monitor the unattended effects that users experience and report,... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 102212 |
| SubjectTerms | Adverse Drug Reaction Reporting Systems Adverse drug reactions Databases, Factual Drug-Related Side Effects and Adverse Reactions - diagnosis Dynamic temporal intervals Early signal detection Graph-based algorithm Humans Pharmacovigilance Pharmacovigilance datasets Signal detection |
| Title | TEDAR: Temporal dynamic signal detection of adverse reactions |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0933365721002050 https://dx.doi.org/10.1016/j.artmed.2021.102212 https://www.ncbi.nlm.nih.gov/pubmed/34823837 https://www.proquest.com/docview/2604016553 |
| Volume | 122 |
| WOSCitedRecordID | wos000722509400002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1873-2860 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007416 issn: 0933-3657 databaseCode: AIEXJ dateStart: 19950201 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9swFBZrOsZeuq27ZZeiwd6CQyxbkr03b8tubKWUDvJmFEUuLkEOcVLKfv2OLlazha7twyCYWLEU29_no6Pjc0HoreScqVSoSFUqj1JQWSMhGY0SVrGsslOQTZn_nR8eZpNJfuSNOa0tJ8C1zi4u8sV_hRraAGwTOnsLuMOg0ADfAXTYAuywvRnw44_FsbOa26xT88HMVZ0fGF8Ns6tWSnaKojAFmVtTO8VFOLSb2mqxtJ5Etq7HZurOWm-9ky8WwkfMmKLEtW6C6UbMrX56VKvVMrS-b7SG_tbLtoYh9a_w0-d6fWrrgQ-Om1bMp2LTMEHiDScPb2FMEsDc5Z8OwtZFIXtxaZabzot6S5I7o8LZEO4jXNHQ_MHw8vA_E2f_NaEFN8POg-2sdKOUZpTSjbKDdgmnedZDu8XX8eRbmL6NimoTNPqz7-ItrVPg9tlcpc9ctV6xesvJQ7TnFxy4cER5hO4ovY8edMU8sJft--jeD4_oY-Qo9A53BMKeQNgRCAcC4abCnkA4EOgJ-vlpfPLhS-TLbEQStLdVlHIBq2TFiQBZTqpcxSLjpOKpVJRluZLmaaZiRBUVoJ1nSSLIaMriWZxTMq1E8hT1dKPVc4R5TGZCxFQSPktzJeAzqiSTcspUIoXso6S7WaX0OehNKZR5-S-o-igKvRYuB8s1x9MOh7KLL4YZsQRqXdOPh35e_3R65Q16vungLkE8m3duQqtm3ZaEwSwZM0qTPnrmeBCuweSVMgaiF7e8vpfo_uXz9gr1Vsu1eo3uyvNV3S4P0A6fZAee1b8B6r-7ZA |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=TEDAR%3A+Temporal+dynamic+signal+detection+of+adverse+reactions&rft.jtitle=Artificial+intelligence+in+medicine&rft.au=Aparo%2C+Antonino&rft.au=Sala%2C+Pietro&rft.au=Bonnici%2C+Vincenzo&rft.au=Giugno%2C+Rosalba&rft.date=2021-12-01&rft.issn=0933-3657&rft.volume=122&rft.spage=102212&rft_id=info:doi/10.1016%2Fj.artmed.2021.102212&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_artmed_2021_102212 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0933-3657&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0933-3657&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0933-3657&client=summon |